Stock Earnings

Question 1

Molecular Partners AG의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Molecular Partners AG의 총 자산은 $158이며, 순loss입니다.

Question 2

MLLCF의 주요 재무 비율은 무엇인가요?

Accepted Answer

Molecular Partners AG의 유동비율은 9.87이고, 순이익률은 -1,350, 주당 매출은 $0.11입니다.

Question 3

Molecular Partners AG의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Molecular Partners AG largest revenue segment is Biopharmaceutical Products, at a revenue of 7,038,000 in the most earnings release.For geography, Switzerland is the primary market for Molecular Partners AG, at a revenue of 7,038,000.

Question 4

Molecular Partners AG은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Molecular Partners AG의 순loss은 $-54입니다.

Question 5

Molecular Partners AG에 부채가 있나요?

Accepted Answer

yes, Molecular Partners AG의 부채는 16입니다.

Question 6

Molecular Partners AG의 발행 주식은 몇 주인가요?

Accepted Answer

Molecular Partners AG의 총 발행 주식은 36.86주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	4	7	189	9	9
Revenue Growth (YoY)	-100%	-43%	-96%	2,000%	0%	-55%
Cost of Revenue	--	0	0	1	0	0
Gross Profit	--	4	7	188	9	8
Selling, General & Admin	16	17	18	21	16	11
Research & Development	44	46	46	47	53	53
Operating Expenses	60	66	68	71	73	67
Other Non Operating Income (Expenses)	--	0	0	0	0	0
Pretax Income	-64	-54	-61	117	-63	-62
Income Tax Expense	0	0	0	0	0	0
Net Income	-64	-54	-61	117	-63	-62
Net Income Growth	-7%	-11%	-152%	-286%	2%	72%
Shares Outstanding (Diluted)	37.16	34.03	32.77	32.47	31	25
Shares Change (YoY)	13%	4%	1%	5%	24%	17%
EPS (Diluted)	-1.74	-1.58	-1.89	3.62	-2.05	-2.51
EPS Growth	-17%	-16%	-152%	-276%	-18%	48%
Free Cash Flow	-57	-59	-59	117	-92	-30
Free Cash Flow Per Share	-1.53	-1.73	-1.8	3.6	-2.96	-1.19
Gross Margin	--	100%	100%	99.47%	100%	88.88%
Operating Margin	0%	-1,525%	-871.42%	61.37%	-700%	-644.44%
Profit Margin	0%	-1,350%	-871.42%	61.9%	-700%	-688.88%
Free Cash Flow Margin	0%	-1,475%	-842.85%	61.9%	-1,022.22%	-333.33%
EBITDA	-58	-59	-59	118	-61	-56
EBITDA Margin	0%	-1,475%	-842.85%	62.43%	-677.77%	-622.22%
D&A For EBITDA	2	2	2	2	2	2
EBIT	-60	-61	-61	116	-63	-58
EBIT Margin	0%	-1,525%	-871.42%	61.37%	-700%	-644.44%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Molecular Partners AG (MLLCF) Price

MLLCF Stock Price Chart

MLLCF Income

Follow-Up Questions